Advertisement

Orthobiologic Standardization and Clinical Outcome Measurement

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Physical Medicine and Rehabilitation Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Chahla J.
        • Cinque M.E.
        • et al.
        A Call for Standardization in Platelet-Rich Plasma Preparation Protocols and Composition Reporting.
        The J Bone Joint Surg. 2017; 99: 1769-1779https://doi.org/10.2106/JBJS.16.01374
        • Fadadu P.P.
        • Mazzola A.J.
        • Hunter C.W.
        • et al.
        Review of concentration yields in commercially available platelet-rich plasma (PRP) systems: a call for PRP standardization.
        Reg Anesth Pain Med. 2019; 44: 652-659
        • Mautner K.
        • Malanga G.A.
        • Smith J.
        • et al.
        A Call for a Standard Classification System for Future Biologic Research: The Rationale for New PRP Nomenclature.
        PM R The J Inj Funct Rehabil. 2015; 7: S53-S59
      1. The History of Drug Regulation. U.S. Food and Drug Administration.
        (Available at:) (Accessed February 6, 2022)
        • Kozlowski S.
        CDER Conversation: Ensuring That Standardization Does Not Impede Biological Product Innovation. In: FDA.gov.
        (Available at:) (Accessed February 6, 2022)
      2. Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use. Food and Drug Administration Center for Biologics Evaluation and Research.
        (Available at:) (Accessed February 6, 2022)
      3. CFR- Code of Federal Regulatioms Title 21. Food and Drug Administration Department of Health and Human Services. Subchapter F- Biologics.
        (Available at:) (Accessed February 6, 2022)
        • Fadadu P.P.
        • Anthony J.M.
        • Hunter C.W.
        • Davis T.T.
        Review of Concentration Yields in Commercially Available Platelet-Rich Plasma (PRP) Systems: A Call for PRP Standardization.
        Reg Anesth Pain Med. 2019; https://doi.org/10.1136/rapm-2018-100356
        • Carr B.J.
        • Canapp S.O.
        • Mason D.R.
        • et al.
        Canine Platelet-Rich Plasma Systems: A Prospective Analysis.
        Front Vet Sci. 2015; 2: 73
        • Giusti Ilaria
        • D’Ascenzo Sandra
        • Mancò Annalisa
        • et al.
        Platelet Concentration in Platelet-Rich Plasma Affects Tenocyte Behavior in Vitro.
        Biomed Res Int. 2014; 2014: 630870
        • Riboh J.C.
        • Saltzman B.M.
        • Lisa Fortier Adam B. Yanke
        • et al.
        Effect of Leukocyte Concentration on the Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis.
        Am J Sports Med. 2016; 44: 792-800
        • Kearney R.S.
        • Ji C.
        • Warwick J.
        • et al.
        Effect of Platelet Rich plasma injection versus Sham injection on Tendon Dysfunction Patients with Chronic Midportion Achilles tendinopathy: A Randomized Clinical Trial.
        JAMA. 2021; 326: 137-144
        • Bennell K.L.
        • Paterson K.L.
        • Metcalf B.R.
        • et al.
        Effect of Intra-Articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.
        JAMA: The J Am Med Assoc. 2021; 326: 2021-2030
        • Kuznetsov S.A.
        • Mankani M.H.
        • Bianco P.
        • et al.
        Enumeration of the Colony-Forming Units-Fibroblast from Mouse and Human Bone Marrow in Normal and Pathological Conditions.
        Stem Cell Res. 2009; 2: 83-94
        • Hernigou Ph
        • Poignard A.
        • Beaujean F.
        • et al.
        Percutaneous Autologous Bone-Marrow Grafting for Nonunions. Influence of the Number and Concentration of Progenitor Cells.”.
        The J Bone Joint Surg Am Volume. 2005; 87: 1430-1437
        • Berger D.R.
        • Centeno C.J.
        • Steinmetz N.J.
        Platelet lysates from aged donors promote human tenocyte proliferation and migration in a concentration-dependent manner.
        Bone Joint Res. 2019; 8: 32-40
        • Fang W.H.
        • Chen X.T.
        • Vangsness C.T.
        Ultrasound-Guided Knee Injections Are More Accurate Than Blind Injections: A Systematic Review of Randomized Controlled Trials.
        Arthrosc Sports Med Rehabil. 2021; 3: e1177-e1187